Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Nymox Breaking Through.

|Includes:Nymox Pharmaceutical Corporation (NYMX)

Nymox 'NX-1207' much more powerful, long lasting, and safer than originally estimated. Dr. Paul Averback, the CEO and inventor of NX-1207, thought that the test subjects would require one dose of the drug per year, but it seems that the drug is so powerful that it resolves the BHP with one dose and the effect of that one dose lasts for more than 6.5 years. WOW! Looks like a block buster thus far, and with phase 3 for BPH and phase 2 for prostate cancer results reporting with in the next 60 days, there is no limit. Assuming that all goes well, FDA review will happen with in the next year or so, so hang on to your hats.

Disclosure: I am long NYMX.

Stocks: NYMX